Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -237.19%-2.22B | ---- | 21.80%-658.76M | ---549.75M | -38.60%-343.62M | 53.83%-842.36M | 67.09%-483.37M | ---247.92M | -67.43%-1.82B |
| Profit adjustment | ||||||||||
| Interest expense - adjustment | ---- | 11.30%27.26M | ---- | 109.84%24.49M | --11.16M | 297.04%5.1M | 121.99%11.67M | 90.20%7.63M | --1.28M | -79.62%5.26M |
| Dividend (income)- adjustment | ---- | ---1.53M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Investment loss (gain) | ---- | -552.69%-1.09M | ---- | 86.03%-167K | ---46K | -70.37%-46K | 82.53%-1.2M | 85.23%-962K | ---27K | -428.67%-6.84M |
| Attributable subsidiary (profit) loss | ---- | --215K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -120.83%-607K |
| Impairment and provisions: | ---- | 161.21%4.66M | ---- | -47.53%1.78M | --578K | 22.39%913K | 229.46%3.4M | 86.47%1.79M | --746K | -97.63%1.03M |
| -Impairmen of inventory (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | --1.8M | --1.86M | ---- | ---- |
| -Impairment of trade receivables (reversal) | ---- | 161.21%4.66M | ---- | 11.78%1.78M | --578K | 22.39%913K | 54.65%1.6M | -107.49%-72K | --746K | -97.63%1.03M |
| Revaluation surplus: | ---- | 455.95%2.42B | ---- | -7.08%434.97M | --424.64M | 273.59%269.77M | -38.25%468.13M | -72.31%204.45M | --72.21M | 1,184.24%758.09M |
| -Fair value of investment properties (increase) | ---- | ---- | ---- | ---- | ---- | ---- | -145.58%-16.97M | ---16.97M | ---- | --37.24M |
| -Other fair value changes | ---- | 455.95%2.42B | ---- | -10.33%434.97M | --424.64M | 273.59%269.77M | -32.70%485.1M | -70.01%221.42M | --72.21M | 1,121.15%720.85M |
| Asset sale loss (gain): | ---- | -102,944.94%-254.03M | ---- | 100.25%247K | --112K | -152.63%-96K | -191,963.46%-99.77M | -199,125.49%-101.5M | ---38K | 116.67%52K |
| -Loss (gain) from sale of subsidiary company | ---- | -25,390,300.00%-253.9M | ---- | 100.00%1K | ---- | ---- | ---100.13M | ---101.85M | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -150.81%-125K | ---- | -32.04%246K | --112K | -152.63%-96K | 596.15%362K | 572.55%343K | ---38K | 116.67%52K |
| Depreciation and amortization: | ---- | 4.82%61.09M | ---- | -9.53%58.28M | --29.55M | -20.69%13.9M | -2.34%64.42M | 4.32%50.32M | --17.53M | 40.86%65.96M |
| -Depreciation | ---- | -18.59%37.28M | ---- | -11.83%45.79M | --23.39M | -25.38%10.83M | -18.18%51.94M | -13.29%40.92M | --14.52M | 37.11%63.48M |
| -Amortization of intangible assets | ---- | 90.65%23.8M | ---- | 0.06%12.49M | --6.16M | 1.89%3.07M | 403.55%12.48M | 796.00%9.41M | --3.01M | 370.21%2.48M |
| Special items | ---- | -52.12%6.52M | ---- | 8.70%13.62M | --7.23M | 19.53%3.1M | -90.46%12.53M | -72.66%9.19M | --2.59M | 66.32%131.36M |
| Operating profit before the change of operating capital | ---- | 131.90%40.05M | ---- | 67.24%-125.54M | ---76.53M | 66.81%-50.99M | 55.96%-383.17M | 51.93%-312.45M | ---153.62M | -4.35%-870.01M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 225.35%6.61M | ---- | -714.04%-5.28M | ---6.45M | -1,849.49%-5.79M | -108.82%-648K | -239.35%-1.75M | ---297K | 298.03%7.35M |
| Accounts receivable (increase)decrease | ---- | -274.99%-122.9M | ---- | -1,138.83%-32.78M | ---58.16M | 19.10%-58.11M | 106.78%3.16M | 164.86%45M | ---71.84M | 0.42%-46.53M |
| Accounts payable increase (decrease) | ---- | 153.59%47.62M | ---- | -151.37%-88.87M | ---109.52M | -175.09%-65M | 153.05%173.01M | 139.51%92.33M | --86.55M | -181.08%-326.15M |
| Special items for working capital changes | ---- | -162.34%-45.58M | ---- | 2,941.31%73.11M | --57.86M | 288.73%46.84M | 106.11%2.4M | 131.22%13.43M | --12.05M | -8,378.95%-39.33M |
| Cash from business operations | 194.36%53.52M | 58.62%-74.2M | 70.58%-56.72M | 12.62%-179.34M | ---192.79M | -4.63%-133.04M | 83.90%-205.26M | 83.57%-163.43M | ---127.15M | -164.75%-1.27B |
| Other taxs | -154.55%-56K | -93.68%6K | -117.32%-22K | 138.78%95K | --127K | ---- | -2,350.00%-245K | -2,350.00%-245K | ---46K | ---10K |
| Net cash from operations | 194.22%53.47M | 58.61%-74.2M | 70.55%-56.74M | 12.78%-179.25M | ---192.67M | -4.60%-133.04M | 83.88%-205.5M | 83.55%-163.68M | ---127.2M | -164.75%-1.27B |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | ---- | --1.53M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Sale of fixed assets | -84.38%82K | -26.13%636K | -28.67%525K | -33.67%861K | --736K | 435.94%686K | 71.69%1.3M | 39.48%809K | --128K | 347.34%756K |
| Purchase of fixed assets | 89.35%-471K | -130.44%-8.25M | -199.73%-4.42M | 78.50%-3.58M | ---1.48M | 79.77%-517K | -2.34%-16.64M | 51.35%-6.28M | ---2.56M | 92.82%-16.26M |
| Purchase of intangible assets | ---2.31M | 81.54%-547K | ---- | -716.25%-2.96M | ---1.44M | ---- | -15.61%-363K | -15.61%-363K | ---- | 82.78%-314K |
| Sale of subsidiaries | ---- | -2,607,200.00%-26.07M | ---26.1M | -100.00%-1K | ---- | ---- | --78.17M | ---- | ---- | ---- |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---16K | ---16K | ---16K | ---- | 70.62%-9.01M | ---- | ---103.43M |
| Recovery of cash from investments | 300.82%152.5M | 114.56%298.59M | -42.39%38.05M | -45.79%139.17M | --66.05M | 722.80%66.05M | -93.13%256.7M | -94.68%197.46M | --8.03M | -19.68%3.73B |
| Cash on investment | -752.43%-120.19M | -81.03%-297.8M | 81.45%-14.1M | 34.28%-164.5M | ---76M | -164.78%-71M | 93.64%-250.32M | 95.06%-194.32M | ---26.82M | 15.40%-3.94B |
| Net cash from investment operations | 589.55%29.61M | -2.84%-31.91M | 50.21%-6.05M | -145.07%-31.03M | ---12.15M | 77.37%-4.8M | 121.42%68.85M | 95.65%-11.69M | ---21.22M | -174.79%-321.4M |
| Net cash before financing | 232.31%83.08M | 49.54%-106.11M | 69.34%-62.79M | -53.88%-210.28M | ---204.82M | 7.12%-137.85M | 91.44%-136.65M | 86.12%-175.37M | ---148.42M | -2,987.13%-1.6B |
| Cash flow from financing activities | ||||||||||
| New borrowing | 43.46%261.09M | 68.62%444.16M | 9.04%182M | 96.58%263.4M | --166.92M | --92.2M | 106.78%133.99M | -79.05%13.57M | ---- | -83.80%64.8M |
| Refund | -322.70%-421.01M | -227.05%-229M | -896.00%-99.6M | 26.51%-70.02M | ---10M | ---- | -1,055.52%-95.27M | -55.48%-9.24M | ---5.09M | 99.34%-8.25M |
| Issuing shares | ---- | 13,045.00%684.99M | ---- | -98.27%5.21M | --5.21M | ---- | -65.38%301.02M | -38.76%295.14M | --38.15M | -53.08%869.49M |
| Interest paid - financing | 55.82%-8.15M | -42.30%-30.97M | -20.02%-18.45M | -398.26%-21.76M | ---15.37M | -24.53%-1.6M | 93.68%-4.37M | 94.59%-3.67M | ---1.28M | -2,394.55%-69.15M |
| Dividends paid - financing | ---- | ---2.51M | ---2.51M | ---- | ---- | ---- | ---4.31M | ---4.31M | ---- | ---- |
| Absorb investment income | ---- | ---- | ---- | 5.38%59.54M | ---- | ---- | --56.49M | --56.49M | ---- | ---- |
| Issuance expenses and redemption of securities expenses | -73.65%-87.87M | -5,451.10%-191.85M | -2,076.47%-50.6M | 90.30%-3.46M | ---2.33M | ---- | -11,811.71%-35.62M | ---35.62M | ---- | 99.36%-299K |
| Other items of the financing business | ---47M | ---279.58M | ---- | ---- | ---- | ---- | ---48.48M | ---- | ---- | ---- |
| Adjustment item of financing business | ---- | ---- | ---- | ---- | ---- | ---2.16M | ---- | ---- | ---- | ---- |
| Net cash from financing operations | -220,626.39%-317.56M | 80.14%373M | -99.89%144K | -26.68%207.06M | --132.41M | 221.94%83.14M | -66.12%282.43M | -35.22%295.58M | --25.83M | -19.96%833.72M |
| Effect of rate | 28.77%-703K | -70.37%988K | -129.58%-987K | -82.04%3.34M | --3.34M | -165.32%-1.05M | 588.73%18.57M | 351.13%8.91M | --1.61M | 79.88%-3.8M |
| Net Cash | -274.28%-234.48M | 8,393.57%266.89M | 13.48%-62.65M | -102.21%-3.22M | ---72.41M | 55.38%-54.71M | 119.12%145.77M | 114.89%120.21M | ---122.59M | -177.01%-762.36M |
| Begining period cash | 50.24%801.05M | 0.02%533.17M | 0.02%533.17M | 44.57%533.05M | --533.05M | 44.57%533.05M | -67.51%368.72M | -67.51%368.72M | --368.72M | 592.90%1.13B |
| Cash at the end | 20.52%565.86M | 50.24%801.05M | 1.20%469.54M | 0.02%533.17M | --463.98M | 92.67%477.3M | 44.57%533.05M | 53.63%497.83M | --247.73M | -67.51%368.72M |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- | -- | Unqualified Opinion |
| Auditor | -- | KPMG | -- | KPMG | -- | -- | KPMG | -- | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.